CNE100001070
CNE100001070
QIANHONG BIO-PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.571.276.512 | 1.526.242.787 | 3.0% |
| Cost of Revenue | 654.347.578 | 689.067.136 | 5.0% |
| Gross Profit | 916.928.934 | 837.175.651 | 9.5% |
| 584.418.743 | 542.694.019 | 7.7% | |
| Operating Income | 332.510.191 | 294.481.632 | 12.9% |
| Pretax Income | 450.181.946 | 395.838.975 | 13.7% |
| Net Income Common Stockholders | 398.795.540 | 356.032.007 | 12.0% |
| -- | -- | -- | |
| -- | -- | -- |